Cutaneous (skin) hemangiosarcoma in dogs.

What it is

Hemangiosarcoma (HSA) is a malignant cancer of the cells that line blood vessels. The splenic and cardiac forms are well known for their aggressive behavior; the cutaneous (skin-only) form is a related but biologically distinct entity with a meaningfully better prognosis when it stays in the skin.

Cutaneous HSA commonly appears in areas of thin coat and sun-exposed skin — the ventral abdomen, prepuce, eyelids, and inner thighs. Short-coated, light-skinned breeds (Whippets, Salukis, Dalmatians, white Bulldogs) are over-represented, supporting a UV-related etiology in at least some cases.

Signs to watch for

• A new red, purple, or black raised lesion on thin-coated skin — particularly on the belly, eyelids, or inner thighs.
• A lesion that bleeds easily or ulcerates.
• Multiple similar-appearing lesions in sun-exposed areas — common with the UV-related form.

How veterinarians diagnose it

Fine-needle aspiration of a vascular lesion has variable yield — pathologists often need a tissue biopsy to confirm HSA and distinguish dermal (skin-only) from subcutaneous (deeper tissue) involvement.

Staging for cutaneous HSA depends on depth: skin-only lesions may need only local imaging plus chest X-rays, while subcutaneous or hypodermal lesions warrant full staging — abdominal ultrasound, echocardiogram, and chest radiographs — to rule out internal disease.

What treatment usually looks like

• Surgical excision with wide margins is the primary therapy and is often curative for skin-only lesions.
• Adjuvant chemotherapy (doxorubicin-based) is typically reserved for subcutaneous or deeper lesions, or for cases with high-risk histologic features.
• Sun protection (physical, like clothing, plus avoidance of midday outdoor time) is reasonable for breeds prone to UV-related disease, especially after diagnosis.

Prognosis

Skin-only (dermal) cutaneous HSA removed with clean margins has a substantially better prognosis than splenic HSA — published median survival can exceed two years for some cases.

Subcutaneous or hypodermal HSA carries a worse prognosis, more in line with visceral HSA, because by the time it's diagnosed it has often already accessed deeper vasculature.

Questions to ask your vet

• Is this dermal-only or does it extend into the subcutis?
• Have we fully staged — bloodwork, ultrasound, chest X-rays?
• Were the surgical margins clean? Do we need re-excision?
• Does my dog need adjuvant chemotherapy, or is surgery alone sufficient?
• Should we be testing for or watching other suspicious skin lesions?

Where to learn more

Veterinary teaching hospitals at most accredited US vet schools maintain owner-facing fact sheets on common cancers. Peer-reviewed journals — JAVMA, Veterinary and Comparative Oncology, Frontiers in Veterinary Science — are accessible through PubMed. The American College of Veterinary Internal Medicine (ACVIM) and the Veterinary Cancer Society publish consensus statements you can ask your vet to walk you through.

For clinical trials enrolling dogs with this diagnosis, see the SciRouter Vet trial finder — we index AVMA, NCI COTC, and twelve university registries.